ArticleCureus2026
Comparative Analysis of Ki-67 Proliferation Index in Colorectal Adenomas and Adenocarcinomas: An Immunohistochemical Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionColorectal carcinoma (CRC) is one of the most common cancers in various parts of the world. The evolution of CRC follows a stepwise genetic acquisition of mutations and a resultant transition from normal mucosa to adenoma and, ultimately, adenocarcinoma. The goal of the study was to assess the different immunohistomorphologic characters in adenomas and adenocarcinomas using the Ki-67 tumor proliferation marker that may have diagnostic or prognostic relevance. Materials and methods: This descriptive study was conducted on 40 paraffin-embedded tissue blocks collected from the colorectal tissues in a tertiary care hospital in Chennai, Southern India. Ki-67 proliferation index (PI) was analyzed by immunohistochemically stained slides by a set of two pathologists to eradicate bias. Results: Tissue samples from 25 (62.5%) male and 15 (37.5%) female patients with a mean age of 56.9 ± 16.09 (age range six to 83 years) and a median age of 60 years were included in the study. Adenocarcinomas comprised 24 (60%), whereas 16 (40%) cases were adenomas. There was a significant mean difference between adenomas (Mean PI = 30.97 ± 11.44) and adenocarcinomas (Mean PI = 46.33 ± 25.16) when compared with Ki-67 PI (%), with a p-value = 0.02 (< 0.05). Conclusions: The Ki-67 immunohistochemical technique is a simple and reproducible technique. A gradual increase in expression of Ki-67 was observed from low-grade adenomas to high-grade adenomas and adenocarcinomas, which may serve as a routine tumor proliferation marker that can be routinely used as a diagnostic or prognostic marker in CRCs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.